$CRNX News

Evercore ISI Group Maintains Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $88

Crinetics Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation

Oppenheimer Maintains Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $84

Citizens Maintains Market Outperform on Crinetics Pharmaceuticals, Lowers Price Target to $95

Crinetics Pharmaceuticals, Inc. (CRNX) Q1 2026 Earnings Call Transcript

Crinetics Pharmaceuticals (NASDAQ:CRNX) Beats Q1 Expectations on Strong PALSONIFY Launch, Stock Slips After Hours

Crinetics Pharmaceuticals Q1 EPS $(1.23) Beats $(1.25) Estimate, Sales $10.306M Beat $8.512M Estimate

The Bull Case For Crinetics Pharmaceuticals (CRNX) Could Change Following EU Nod For Oral Acromegaly Drug PALSONIFY

Will Aquestive Therapeutics (AQST) Report Negative Q1 Earnings? What You Should Know

Crinetics Pharmaceuticals (CRNX): Billionaire Tom Steyer Likes This Pharma Stock

Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for

Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why

Citizens Maintains Market Outperform on Crinetics Pharmaceuticals, Raises Price Target to $97

Crinetics Pharmaceuticals Announces the European Commission Approval of PALSONIFY® (Paltusotine) for the Treatment of Acromegaly in Adults

Crinetics Pharmaceuticals Obtains European Commission Approval For PALSONIFY For The Treatment Of Acromegaly in Adults; Crinetics' First Regulatory Approval Outside Of The U.S., With First Launch Planned For Germany And Austria

Amneal Pharmaceuticals (AMRX) Q1 Earnings and Revenues Surpass Estimates

Neutrolis Appoints Caren Deardorf as Chief Business & Strategy Officer

Crinetics Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026

Crinetics Director Sells 5,000 Shares With Stock Down 4%, but Here's What Matters More

Crinetics Pharmaceuticals Announces Submission of Marketing Authorization Application in Brazil for Palsonify™ (Paltusotine) in Acromegaly